Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRC
2126
Commerce.com Inc Series 1
CMRC
$184M
| $2.3M | ﹤0.01% |
263,694
+187,181
| +245% | +$2.03M |
|
2127
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
| $2.3M | ﹤0.01% |
93,387
+15,554
| +20% | +$390K |
|
2128
Visteon
VC
$2.78B
| $2.3M | ﹤0.01% |
17,574
+10,032
| +133% | +$1.34M |
|
|
AHRT
2129
AH Realty Trust
AHRT
$517M
| $2.3M | ﹤0.01% |
199,712
+84,745
| +74% | +$977K |
|
2130
CALL
TG Therapeutics
TGTX
$7.62B
| $2.3M | ﹤0.01% |
+194,100
| New | +$1.41M |
|
2131
Aecom
ACM
$9.75B
| $2.29M | ﹤0.01% |
26,970
-20,370
| -43% | -$1.6M |
|
2132
e.l.f. Beauty
ELF
$5.8B
| $2.29M | ﹤0.01% |
41,379
-73,167
| -64% | -$3.58M |
|
|
NXDT
2133
NexPoint Diversified Real Estate Trust
NXDT
$238M
| $2.29M | ﹤0.01% |
204,075
| – | – |
|
2134
Recursion Pharmaceuticals
RXRX
$1.72B
| $2.29M | ﹤0.01% |
296,600
+184,366
| +164% | +$1.81M |
|
2135
CALL
Lam Research
LRCX
$390B
| $2.27M | ﹤0.01% |
+54,000
| New | +$2.26M |
|
|
PRMW
2136
DELISTED
Primo Water Corporation
PRMW
| $2.27M | ﹤0.01% |
146,049
+33,139
| +29% | +$482K |
|
2137
Bankunited
BKU
$3.36B
| $2.27M | ﹤0.01% |
66,748
-21,256
| -24% | -$751K |
|
2138
Ormat Technologies
ORA
$6.64B
| $2.27M | ﹤0.01% |
26,197
-19,528
| -43% | -$1.75M |
|
2139
Upbound Group
UPBD
$1.16B
| $2.27M | ﹤0.01% |
100,464
+56,045
| +126% | +$1.2M |
|
2140
Knowles
KN
$3.34B
| $2.26M | ﹤0.01% |
137,635
-13,855
| -9% | -$201K |
|
2141
Towne Bank
TOWN
$3.42B
| $2.26M | ﹤0.01% |
73,226
+2,990
| +4% | +$92.7K |
|
2142
Morningstar
MORN
$7.53B
| $2.25M | ﹤0.01% |
10,401
-5,051
| -33% | -$1.15M |
|
|
ETWO
2143
DELISTED
E2open Parent Holdings
ETWO
| $2.25M | ﹤0.01% |
383,540
+291,319
| +316% | +$1.67M |
|
|
CUTR
2144
DELISTED
Cutera, Inc.
CUTR
| $2.24M | ﹤0.01% |
50,736
+7,533
| +17% | +$343K |
|
2145
Geron
GERN
$949M
| $2.24M | ﹤0.01% |
925,205
+569,474
| +160% | +$1.28M |
|
2146
WesBanco
WSBC
$4B
| $2.23M | ﹤0.01% |
60,365
+14,767
| +32% | +$567K |
|
|
LCW
2147
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
| $2.23M | ﹤0.01% |
220,973
| – | – |
|
2148
Icon
ICLR
$12.7B
| $2.22M | ﹤0.01% |
11,418
+3,632
| +47% | +$720K |
|
2149
First Financial Bankshares
FFIN
$4.97B
| $2.22M | ﹤0.01% |
64,446
+724
| +1% | +$27.4K |
|
|
NOAH
2150
Noah Holdings
NOAH
$603M
| $2.22M | ﹤0.01% |
142,965
-40,000
| -22% | -$584K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.